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Cultures were incubated overnight at 18 °C before harvesting cells and purification of recombinant His tagged GDH2.
Protein purification Cell pellets derived from the E. coli protein expression, were resuspended in 25 mL lysis buffer (50 mM phosphate, 500 mM NaCl, and 10 mM imidazole, pH 7.0). Lysozyme (1 mg/mL) was added to the cell resuspension which was then incubated at 30 °C for 1 h. Cells were disrupted by sonication and the lysate was clarified by centrifugation (4 °C, 40 min, 10,000 x g). The soluble cell extract was loaded onto a HisTrap TM FF crude column and purified by FPLC. The column was washed with 20 mM phosphate buffer (pH 7.0) containing 20 and 60 mM imidazole and 500 mM NaCl. Purified SttH was eluted in phosphate buffer containing 500 mM imidazole, Fre and GDH2 at 250 mM imidazole. Protein samples were subjected to buffer exchange with phosphate buffer containing 10 % glycerol using a Vivaspin 20 centricon (10,000 MWCO) before subsequently storing at ̶ 20 °C. Table S1 were used to produce SttH and PyrH mutants using standard methods.
Mutagenesis The primers detailed in

Biotransformations, and characterisation of activity and regioselectivity
Enzyme assays The following conditions were used for assays to determine regioselectivity and % conversions of halogenase reactions. Purified halogenase enzyme (10 µM) was incubated at 30 °C with shaking for 1 h with Fre (1 µM), GDH2 (6 µM), FAD (7.5 µM), NADH (200 µM), MgCl 2 (50 mM), glucose (20 mM) and substrate (0.5 mM) in a total volume of 100 µL in 10 mM potassium phosphate buffer, pH 7.0. Reactions were stopped by incubating at 95˚C for 5 min and precipitated protein was removed by centrifugation before analysis via HPLC on an Agilent Technologies 1260 system using an Agilent Zorbax Eclipse Plus C18 4.6 x 100 mm x 3.5 µm column. For tryptophan, 3-indolepropionic acid (33% isocratic gradient H 2 O/acetonitrile + 0.1% formic acid) and N-phenylanthranilic acid (gradient 5 -95% H 2 O/acetonitrile + 0.1% formic acid), absorbance was measured at 280 nm. Nmethyltryptophan, kynurenine, anthranilamide and anthranilic acid absorbance were measured at 254 nm, with a 5 min gradient 5 -75% H 2 O/acetonitrile + 0.1% formic acid.
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Enzyme Kinetics To obtain kinetic parameters for selected reactions, the concentration of the assay components were varied according to conditions required to provide the best fit for the Michaelis-Menten curve. However in each case the total assay volume was 150 µL and the Fre concentration was always in excess in order to ensure the production of reduced flavin was not a rate limiting factor. Assays were performed at 30˚C with shaking at 800 rpm. Plates and assay components were pre-incubated at 30˚C. Assays were started by the addition of substrate using a multi-channel pipette. Substrate was added at 15 second intervals and the reaction terminated with the addition of formic acid. All assays were performed in triplicate.
Preparative halogenase reactions Larger scale assays were carried out to obtain chlorinated products for characterisation using halogenase (10 µM), Fre (1 µM), GDH2 (6 µM), substrate (2 mM), MgCl 2 (50 mM), FAD (7.5 µM), NADH (200 µM), glucose (20 mM) in 10 mM potassium phosphate buffer, pH 7.0 (10 mL). Assays were run at 30˚C with shaking.
Reactions were stopped by incubating at 95 °C for 5 min and precipitated protein was removed by centrifugation (4 °C, 10 min, 12000 x g) before analysis by HPLC. For reactions with low yield, multiple 10 mL reactions were performed and combined prior to purification by semi-prep HPLC. For tryptophan, 3-indolepropionic acid (33% isocratic gradient H 2 O/acetonitrile + 0.1% formic acid) and N-phenylanthranilic acid (5 -95% H 2 O/acetonitrile + 0.1% formic acid), absorbance was measured at 280 nm. All other substrates and products absorbance were measured at 254 nm, with a 5 min gradient 5 -75% H 2 O/acetonitrile + 0.1% formic acid. Products were subsequently characterised using 1D and 2D NMR and HRMS and are in good agreement with the literature data. [18] pET28a-SttH was transformed into chemically competent E. coli BL21 (DE3) with the pGro7 plasmid encoding GroEL/ES chaperones. LB medium containing kanamycin (50 µg/mL) and chloramphenicol (35 µg/mL) was inoculated with the transformant and incubated at 37 °C overnight. The cells were then diluted 1:100 in fresh LB medium and incubated shaking at 37 °C until an optical density (OD 600nm ) of 0.6. The cells were subsequently induced with addition of IPTG (0.2 mM) and L-arabinose (0.5 mg/mL), before growing for 18 hours at 18 °C, followed by harvesting of cells (4 °C, 20 min, 4000 x g,). Cells from 1.5 L of culture was resuspended in 25 mL 100 mM Na 2 HPO 4 pH 7.4 and lysed by sonication. Following centrifugation (10,000 x g, 30 min, 4 °C), 2.5 U·mL flavin reductase Fre and 1 U·mL alcohol dehydrogenase was added to the lysate and mixed thoroughly. Ammonium sulphate (16.2 g) was added and the mixture cooled S5 and incubated at 4 °C for 2 hours with rocking to precipitate the proteins. Glutaraldehyde (0.5% w/v) was then added and the mixture incubated for a further 2 hours at 4 °C. The combi CLEAs were then spun down and washed (3 x 50 mL, 100 mM, Na 2 HPO 4, pH7.4). The assay was carried out using the combi CLEAs, with 100 mg anthranilamide, 30 mM NaCl, 100 µM NAD + , 10 µM FAD, 5% (v/v) isopropanol in 15 mM Na 2 HPO 4 buffer pH 7.4 (150 mL) at 25°C overnight with shaking. 5-chloroanthranilamide was isolated (33 mg, 25%) using semiprep HPLC. [14] was prepared according to the general procedure described above with tryptophan (0.5 mM) and SttH to give 6-chlorotryptophan (91 % yield Chlorination of 3-indolepropionic acid was carried out according to the general procedure described above with starting material 3-indolepropionic acid and enzyme SttH to give a mixture of 5 and 6-chlorinated products. 6-chloro-3-indolepropionic acid product (11% yield) was isolated by HPLC. 5-Chloro-3-indolepropionic acid (65% yield) was acquired using PyrH (10 M) and was carried out in accordance with the general procedure stated above. [18b, S3] was prepared according to the general procedure described above with kynurenine and SttH to give 5-chlorokynurenine (46% yield). 5-chloroanthranilamide (5a) [18b, S4] was prepared according to the general procedure described above with anthranilamide and SttH to give 5-chloroanthranilamide (30% yield). 
Preparation and assay with SttH combi CLEAs
6-chlorotryptophan (1a)
5-chlorokynurenine (4a)
5-chloroanthranilic acid (6a)
[18b, S4] was prepared according to the general procedure 
N-(4-chlorophenyl)anthranilic acid (7a)
[18b, S5] was prepared according to the general procedure described above with N-phenylanthranilic acid and SttH to give N-(4- Figure S2 . PyrH crystal structure (PDB 2WET) and SttH crystal structure (PDB 5HY5) showing substrate tryptophan, catalytic residues and π-stacking residues. Substrate is modelled in the case of SttH and therefore π-stacking residue SttH F98 like to rotate on binding. Figure S3 . PyrH crystal structure (PDB 2WET) and SttH crystal structure (PDB 5HY5) showing substrate tryptophan, catalytic residues and residues interacting with indole NH. Figure S4 . PyrH crystal structure (PDB 2WET) and SttH crystal structure (PDB 5HY5) showing substrate tryptophan, catalytic residues and side chain hydrogen bonding residues. Substrate is modelled in the case of SttH and therefore residue SttH Q171 is likely to flip into bind in a similar manner to PyrH Q163. Electron density is not present for SttH Q167 which is likely to interact in a similar manner to PyrH Q160 
